International Biotechnology Trust PLC Ligand Pharmaceuticals Inc Transaction History

International Biotechnology Trust PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $629,625 - $877,168	-7,300 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$105.93 - $142.47 $5.19 Million - $6.98 Million	-49,000 Reduced 87.03%	7,300 $918,000
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $2.73 Million - $5.8 Million	21,300 Added 60.86%	56,300 $6 Million
Q3 2018 Nov 14, 2018	SELL	$211.18 - $274.49 $23.1 Million - $30 Million	-109,300 Reduced 75.74%	35,000 $7.36 Million
Q3 2018 Nov 13, 2018	BUY	$211.18 - $274.49 $23.1 Million - $30 Million	109,300 Added 312.29%	144,300 $5.07 Million
Q2 2018 Aug 13, 2018	SELL	$150.77 - $207.98 $1.06 Million - $1.46 Million	-7,000 Reduced 16.67%	35,000 $7.25 Million
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $1.8 Million - $2.37 Million	13,000 Added 44.83%	42,000 $6.94 Million
Q3 2017 Mar 02, 2018	BUY	$120.91 - $137.94 $2.42 Million - $2.76 Million	20,000 Added 222.22%	29,000 $3.95 Million
Q1 2017 Mar 02, 2018	SELL	N/A	-21,000 Reduced 70.0%	9,000 $952,000
Q4 2016 Mar 02, 2018	BUY	N/A	30,000	30,000 $3.05 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.07B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.